LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Etoposide | 0.056667 | 87.14 | 771.67 | 13494 | 12592 | 1.0716 | 1.0346 | MN20160304_L01 | J16 |
MCF 10A-H2B-mCherry | Palbociclib | 1.7783 | 87.14 | 771.67 | 2122 | 12592 | 0.1685 | 0.2854 | MN20160304_L01 | J08 |
MCF 10A-H2B-mCherry | Palbociclib | 1.7783 | 87.14 | 771.67 | 1797 | 12592 | 0.1427 | 0.2335 | MN20160304_L01 | F11 |
MCF 10A-H2B-mCherry | Etoposide | 0.31623 | 87.14 | 771.67 | 5929 | 12592 | 0.4708 | 0.6589 | MN20160304_L01 | E17 |
MCF 10A-H2B-mCherry | Etoposide | 0.31623 | 87.14 | 771.67 | 5362 | 12592 | 0.4258 | 0.6180 | MN20160304_L01 | E08 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 87.14 | 771.67 | 11796 | 12592 | 0.9368 | 0.9678 | MN20160304_L01 | N09 |
MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 87.14 | 771.67 | 10567 | 12592 | 0.8392 | 0.9148 | MN20160304_L01 | J06 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.14 | 771.67 | 7717 | 12592 | 0.6128 | 0.7711 | MN20160304_L01 | N13 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.14 | 771.67 | 11203 | 12592 | 0.8897 | 0.9428 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Taxol | 0.1 | 87.14 | 771.67 | 142 | 12592 | 0.0113 | -0.3431 | MN20160304_L01 | C04 |
MCF 10A-H2B-mCherry | Taxol | 0.00053333 | 87.14 | 771.67 | 9348 | 12592 | 0.7424 | 0.8574 | MN20160304_L01 | G07 |
MCF 10A-H2B-mCherry | Taxol | 0.0002 | 87.14 | 771.67 | 9426 | 12592 | 0.7485 | 0.8613 | MN20160304_L01 | E06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 87.14 | 771.67 | 3307 | 12592 | 0.2626 | 0.4351 | MN20160304_L01 | N15 |
MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.14 | 771.67 | 4495 | 12592 | 0.3570 | 0.5487 | MN20160304_L01 | I06 |
MCF 10A-H2B-mCherry | Etoposide | 0.56234 | 87.14 | 771.67 | 2282 | 12592 | 0.1812 | 0.3089 | MN20160304_L01 | D03 |
MCF 10A-H2B-mCherry | Taxol | 0.0018 | 87.14 | 771.67 | 5957 | 12592 | 0.4731 | 0.6609 | MN20160304_L01 | I22 |
MCF 10A-H2B-mCherry | Palbociclib | 0.31623 | 87.14 | 771.67 | 3014 | 12592 | 0.2394 | 0.4024 | MN20160304_L01 | H20 |
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.14 | 771.67 | 7079 | 12592 | 0.5622 | 0.7336 | MN20160304_L01 | I11 |
MCF 10A-H2B-mCherry | Taxol | 0.1 | 87.14 | 771.67 | 42 | 12592 | 0.0033 | -0.5145 | MN20160304_L01 | D20 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 87.14 | 771.67 | 5778 | 12592 | 0.4588 | 0.6483 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Etoposide | 0.31623 | 87.14 | 771.67 | 7874 | 12592 | 0.6253 | 0.7800 | MN20160304_L01 | J21 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 87.14 | 771.67 | 8730 | 12592 | 0.6933 | 0.8262 | MN20160304_L01 | N08 |
MCF 10A-H2B-mCherry | Etoposide | 0.56234 | 87.14 | 771.67 | 2139 | 12592 | 0.1699 | 0.2880 | MN20160304_L01 | D05 |
MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 87.14 | 771.67 | 14500 | 12592 | 1.1515 | 1.0713 | MN20160304_L01 | I16 |
MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.14 | 771.67 | 11099 | 12592 | 0.8814 | 0.9383 | MN20160304_L01 | M17 |